Madrigal Pharmaceuticals, Inc. (MDGL) — Analyst estimates
Consensus analyst estimates for Madrigal Pharmaceuticals, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 437.87M | 0.08 | 2 |
| 2027 | 650.62M | 4.43 | 2 |
| 2028 | 3.00B | 26.69 | 11 |
| 2029 | 3.95B | 43.23 | 4 |
| 2030 | 4.97B | 62.31 | 4 |
Consensus analyst estimates by fiscal year.